Sussman Norman has filed 9 insider transactions across 1 company since December 2021.
Most recent transaction: a disposition of 104000 shares of DURECT CORP ($DRRX) on September 11, 2025.
Activity breakdown: 0 open-market purchases and 1 sale.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sept. 11, 2025 | DURECT CORP | $DRRX | Sussman Norman | Chief Medical Officer | D | Stock Option (right to buy) | 104000 | $0.00 | 0.0000 | 31,163,000 | 100.00% | 0.33% |
| Sept. 11, 2025 | DURECT CORP | $DRRX | Sussman Norman | Chief Medical Officer | D | Stock Option (right to buy) | 10000 | $0.00 | 0.0000 | 31,163,000 | 100.00% | 0.03% |
| Sept. 11, 2025 | DURECT CORP | $DRRX | Sussman Norman | Chief Medical Officer | D | Stock Option (right to buy) | 39837 | $0.00 | 0.0000 | 31,163,000 | 100.00% | 0.13% |
| Sept. 11, 2025 | DURECT CORP | $DRRX | Sussman Norman | Chief Medical Officer | D | Stock Option (right to buy) | 69557 | $0.00 | 0.0000 | 31,163,000 | 100.00% | 0.22% |
| Sept. 11, 2025 | DURECT CORP | $DRRX | Sussman Norman | Chief Medical Officer | D | Common Stock | 46425 | $0.00 | 0.0000 | 31,163,000 | 100.00% | 0.15% |
| Sept. 11, 2025 | DURECT CORP | $DRRX | Sussman Norman | Chief Medical Officer | D | Stock Option (right to buy) | 20000 | $0.00 | 0.0000 | 31,163,000 | 100.00% | 0.06% |
| July 11, 2025 | DURECT CORP | $DRRX | Sussman Norman | Chief Medical Officer | A | Common Stock | 46425 | $0.00 | 46,425.0000 | 31,163,000 | 9999.99% | 0.15% |
| Oct. 14, 2024 | DURECT CORP | $DRRX | Sussman Norman | Chief Medical Officer | A | Stock Option (right to buy) | 104000 | $0.00 | 104,000.0000 | 31,038,000 | 9999.99% | 0.34% |
| Dec. 10, 2021 | DURECT CORP | $DRRX | Sussman Norman | Chief Medical Officer | S | Common Stock | 9000 | $1.06 | 0.0000 | 0 | 100.00% | 0.00% |